Steven J. Buhaly - 16 Feb 2023 Form 4 Insider Report for BioSig Technologies, Inc. (BSGM)

Reporting relationship: Chief Financial Officer
Issuer ticker: BSGM
Reported as of: 16 Feb 2023
Net transaction value: $0
SEC form: 4
Accepted by SEC: 17 Feb 2023, 14:03:22 UTC
Prior SEC filing: 08 Feb 2023
Source filing: View source filing
Reporting owner signature: /s/ Steven J. Buhaly

Key filing fact

Steven J. Buhaly filed Form 4 for BioSig Technologies, Inc. (BSGM) on 17 Feb 2023.

Key facts

This page summarizes Steven J. Buhaly's Form 4 filing for BioSig Technologies, Inc. (BSGM).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 17 Feb 2023, 14:03.

Change

Previous filing in this sequence was filed on 08 Feb 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BSGM transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +250,000
Change %
Price: $0.000000
Shares after: 250,000
Date: 16 Feb 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 250,000
Exercise price: $1.25
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock options shall have a quarterly vesting schedule and shall become exercisable as of the date they vest, subject to the terms and conditions of the BioSig Technologies, Inc. 2023 Long-Term Incentive Plan and the stock option agreement by and between the Company and the reporting person.